Cochrane · systematic review · CD006258
Haemodiafiltration, haemofiltration and haemodialysis for end‐stage kidney disease
Nistor, I, Palmer, SC, Craig, JC, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
Kidney and TransplantAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 2 · 50%Low 2 · 50%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: men and women with end‐stage kidney disease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
All‐cause mortality | RR 0.87 [0.72, 1.05] | 11 studies · 3396 participants | Low |
Cardiovascular mortality | RR 0.75 [0.81, 0.92] | 6 studies · 2889 participants | Low |
Nonfatal cardiovascular events | RR 1.23 | 2 studies · 1688 participants | Very low |
Health‐related quality of life | no estimate extracted | 8 studies · 988 participants | Very low |